31,32 Pharmacokinetics of Cysteine and L-Carnitine The pharmacokinetic evaluation of Cysteine and L-Carnitine revealed close similarities in solubility, safety, and metabolic stability, although both compounds showed limited gastrointestinal absorption and restricted systemic distribution
Together, these data indicate that antibody production and plasma cell differentiation are inversely related to G6PD activity
Antioxid Redox Signal 2002
It also described 10 (30%) cases of eosinophilic panniculitis that developed within 3 weeks to 5 months of GLP-1 treatment, 3 (9%) cases of bullous pemphigoid that occurred within the first 2 months, 2 (6%) morbilliform drug eruptions that occurred within 5 weeks, 2 (6%) cases of angioedema that occurred 15 minutes to 2 weeks after treatment initiation, and 7 (21%) other isolated cutaneous reactions
Conclusion: An Honest Assessment of Where the Evidence Stands BPC-157 is not a miracle compound, and it is not a fringe curiosity